Press release
Autologous Cell Therapy Market to Reach USD 47.4 B by 2032 at ~21.7% CAGR
Autologous Cell Therapy Market
As per Maximize Market Research, the global Autologous Cell Therapy Market was valued at approximately USD 9.85 billion in 2024 and is anticipated to reach nearly USD 47.40 billion by 2032, growing at an estimated CAGR of 21.7% between 2025 and 2032
Other projections support strong growth: Coherent Market Insights estimates a value of USD 22.30 billion by 2032 at 22.1% CAGR starting from USD 5.51 B in 2025 , and Acumen Research forecasts expansion from USD 6.1 B in 2022 to USD 34.8 B by 2032 at 19.1% CAGR
Download your sample copy of this report today!https://www.maximizemarketresearch.com/request-sample/171125/
◉ Market Overview & Key Drivers
Oncology applications-notably CAR‐T and T‐cell therapies-dominate (~88.6% share in 2024)
Non‐stem cell therapies make up ~97.4% of current offerings, though stem cell therapies (e.g. MSCs, iPSCs) are the fastest-growing segment
Major source segments: Bone marrow-derived cells accounted for ~44% of revenue in 2022, with mesenchymal stem cells showing the highest growth rate (~22% CAGR)
Hospitals and clinics are the predominant end‐users, driven by specialized infrastructure for collection, processing, and infusion (~USD 6 billion+ in 2022)
◉ Competitive Landscape
Global leaders include Gilead Sciences (Kite Pharma), Novartis, and Bristol‐Myers Squibb, who together exceed 75% share of CAR‐T revenues in 2024, with products such as Yescarta, Kimiyah, and Breyanzi
Key manufacturing and CDMO players include Catalent (via acquisition of MaSTherCell), SCTbio, and Oxford Biomedica, providing end-to-end contract development services and vector production
Secure your sample copy of this report immediately!https://www.maximizemarketresearch.com/request-sample/171125/
◉ Regional Demand & High‐Growth Region
North America led with ~57.9% market share in 2024, driven by FDA approvals, advanced biomanufacturing infrastructure, and aging population demographics
Asia‐Pacific-including China, Japan, India, and South Korea-is the fastest-growing region (~20-22% CAGR), aided by biotech investment and scaling infrastructure
Europe shows robust expansion fueled by supportive EMA policies, Horizon research grants, and tight academia-industry collaboration in markets like Germany, UK, and France
◉ COUNTRY‐SPECIFIC INSIGHTS
Vietnam Opportunity Growth
Vietnam's burgeoning biotech research ecosystem and increasing chronic disease burden drive nascent demand for autologous therapies-for oncology and regenerative indications.
Thailand Trends Growth
Thailand's medical tourism and hospital clusters are catalyzing early adoption of autologous treatments, supported by international partnerships for trial and manufacturing services.
Japan Consolidation Updation
Japanese industry players and academic institutions are engaging with global leaders like Kite, Novartis, and Gilead on oncology-focused autologous therapies. Notably, Metcela Inc. acquired Japan Regenerative Medicine Co. to boost cardiac stem cell developments in 2022
South Korea Innovation Opportunity
South Korea is advancing with regenerative and immunotherapies using mesenchymal and hematopoietic sources; local biotech firms leverage government R&D funding to scale autologous therapy development.
Singapore Benchmarking Trends
Singapore's research-driven healthcare infrastructure and regulatory frameworks allow pilot implementation of cutting-edge autologous therapies and serve as a regional benchmark.
United States Consolidation Trends
In the U.S., Gilead (Kite), Novartis, and Bristol‐Myers Squibb dominate. FDA approvals in 2024-including process optimizations for Yescarta-are accelerating timelines and patient access
Growth in China Trends
China leads APAC with government-driven biotech expansion, domestic CAR-T trials, and manufacturing investments. Collaborations, such as Gilead's with local partners, help scale access locally and globally
Opportunity & Compliance in Europe
European markets, especially Germany, France, and the UK, focus on clinical-grade autologous therapies, particularly in oncology and tissue regeneration. EMA's regulatory clarity and research funding (Horizon 2020+) foster innovation
To learn more about the findings of this research, please check:https://www.maximizemarketresearch.com/market-report/autologous-cell-therapy-market/171125/
◉ Autologous Cell Therapy Market Segment Analysis:
by Product
Mesenchymal Stem Cells
Bone Marrow
Chondrocytes
Haematopoietic Stem Cells
Others
by Type
Autologous Stem Cell Therapies
Car T Cell Therapies
Autologous Non-Stem Cell Therapies
Tumour Infiltrating Lymphocyte Therapies
by Application
Cancer
Orthopaedics
Cardiovascular/Autoimmune Disorders
Neurodegenerative Disorders
Wound Healing
Others
by End-User
Hospitals & Clinics
Academics & Research
Ambulatory Centres
◉ Mergers, Partnerships & Technological Updation
AstraZeneca acquired EsoBiotec for up to USD 1 billion in 2025, targeting in vivo CAR‐T delivery to simplify cell therapy logistics and lower cost barriers
In 2024, Metcela Inc. acquired Japan Regenerative Medicine Co., strengthening its portfolio of cardiac stem cell therapies in Japan
Roche agreed to acquire Poseida Therapeutics for up to USD 1.5 billion to internalize CAR‐T manufacturing and accelerate next‐generation immunotherapies
◉ Key Recent Developments
FDA approved lifileucel (Amntagvi) in February 2024-the first tumor‐infiltrating lymphocyte therapy for melanoma-demonstrating advancement in autologous T‐cell platforms
Over 1,500 clinical trials are now underway globally, underscoring rapid pipeline expansion across oncology and regenerative indications
◉ Get Market Research Latest Trends
Global Metastatic Bone Disease Market https://www.maximizemarketresearch.com/market-report/global-metastatic-bone-disease-market/22267/
Global Fragile X-Syndrome Market https://www.maximizemarketresearch.com/market-report/global-fragile-x-syndrome-market/102731/
Global Hysterectomy Alternatives Market https://www.maximizemarketresearch.com/market-report/global-hysterectomy-alternatives-market/97911/
Extracorporeal Membrane Oxygenation Machine Market https://www.maximizemarketresearch.com/market-report/global-extracorporeal-membrane-oxygenation-machine-market/83413/
Global Orthodontic Retainers Market https://www.maximizemarketresearch.com/market-report/global-orthodontic-retainers-market/91197/
Peanut Allergy Market https://www.maximizemarketresearch.com/market-report/peanut-allergy-market/199509/
Cannula Market https://www.maximizemarketresearch.com/market-report/cannula-market/13045/
Continuous Manufacturing Market https://www.maximizemarketresearch.com/market-report/global-continuous-manufacturing-market/6868/
Global Antimicrobial Susceptibility Testing Market https://www.maximizemarketresearch.com/market-report/global-antimicrobial-susceptibility-testing-market/1281/
Sports Medicine Market https://www.maximizemarketresearch.com/market-report/sports-medicine-market/613/
Pharmaceutical Gelatin Market https://www.maximizemarketresearch.com/market-report/pharmaceutical-gelatin-market/216076/
Global Stroke Management Market https://www.maximizemarketresearch.com/market-report/global-stroke-management-market/35987/
◉ Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
◉ About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autologous Cell Therapy Market to Reach USD 47.4 B by 2032 at ~21.7% CAGR here
News-ID: 4125025 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
India Lubricants Market to Expand from USD 2.70 Billion Liters in 2023 to USD 3. …
◉Opening Paragraph
According to a recent report by Maximize Market Research, the India Lubricants Market was valued at USD 2.70 billion liters in 2023 and is forecast to reach USD 3.86 billion liters by 2030, growing at a compound annual growth rate (CAGR) of 5.24% over the period 2024-2030. The market growth is fueled by rising automotive sales, expansion in industrial and transportation activities, and increasing demand for synthetic and environmentally…
Global Oil Well Cement Market to Rise from USD 1.36 Billion in 2024 to USD 2.41 …
◉ Opening Paragraph
According to a report by Maximize Market Research, the global Oil Well Cement Market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.41 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.4% over the forecast period. The growth is driven by increasing drilling activities (onshore & offshore), demand for high-performance cement classes (especially Class G), and government initiatives…
Global Visualization & 3D Rendering Software Market to Surge from USD 3.38 Billi …
◉ Opening Paragraph
According to a new report by Maximize Market Research, the global Visualization & 3D Rendering Software Market was valued at USD 3.38 billion in 2023 and is projected to reach USD 14.50 billion by 2030, growing at a compound annual growth rate (CAGR) of 23.1% between 2024 and 2030. Key growth factors include rising demand in architectural & visualization, expansion of gaming and media & entertainment industries, and…
Global Nuclear Medicine / Radiopharmaceuticals Market to Grow from USD 6.04 Bill …
◉ Opening Paragraph
According to a report by Maximize Market Research, the global Nuclear Medicine / Radiopharmaceuticals Market was valued at USD 6.04 billion in 2023 and is projected to reach USD 11.05 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0% during the period 2024-2030. The market expansion is propelled by increasing procedural volumes (e.g., SPECT and PET diagnostics), surging demand for therapeutic radiopharmaceuticals, and growing…
More Releases for Cell
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
